Arthritis Research & Therapy

Volume 16 Supplement 1

Lupus 2014: New Targets, New Approaches

Meeting abstracts

Edited by John Esdaile, Paul R Fortin, Matthew Liang, Peter Lipsky and Daniel Wallace

Publication charges for this supplement were funded by the conference.

Lupus 2014: New Targets, New Approaches.

Quebec City, Canada18-20 September 2014

Page 2 of 2

A comprehensive approach to identify approved drugs and treatments for repositioning as therapies for systemic lupus erythematosus

Authors: Amrie C Grammer, Matthew Ryals and Peter E Lipsky

Citation: Arthritis Research & Therapy 2014 16(Suppl 1):A51

Content type: Meeting abstract Published on: 18 September 2014
- View Full Text
- View PDF
Cluster analysis of longitudinal treatment patterns in patients newly diagnosed with systemic lupus erythematosus in the United States

Authors: Hong Kan, Saurabh Nagar, Jeetvan Patel, Daniel J Wallace and Charles Molta

Citation: Arthritis Research & Therapy 2014 16(Suppl 1):A52

Content type: Meeting abstract Published on: 18 September 2014
- View Full Text
- View PDF
Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial

Authors: David Isenberg, Yong Li, Stephen Wax, David Wofsy and Caroline Gordon

Citation: Arthritis Research & Therapy 2014 16(Suppl 1):A53

Content type: Meeting abstract Published on: 18 September 2014
- View Full Text
- View PDF

Previous page
1
2
Next page

Submit manuscript

Follow

Annual Journal Metrics

2022 Citation Impact
4.9 - 2-year Impact Factor
5.7 - 5-year Impact Factor
1.501 - SNIP (Source Normalized Impact per Paper)
1.592 - SJR (SCImago Journal Rank)
2022 Speed
7 days submission to first editorial decision for all manuscripts (Median)
149 days submission to accept (Median)
2022 Usage
3,146,404 downloads
17,226 Altmetric mentions
More about our metrics

ISSN: 1478-6362

Contact us

Submission enquiries: arlene.pura@springernature.com
General enquiries: info@biomedcentral.com